Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
mi
from
Tampa, FL
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
Colon and Rectal Surgery, Incorporated
mi
from
Omaha, NE
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
Colon and Rectal Surgery, Incorporated
mi
from
Omaha, NE
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
Vermont Cancer Center at University of Vermont
mi
from
Burlington, VT
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
Vermont Cancer Center at University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
City of Hope Medical Center
mi
from
Duarte, CA
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated:  4/5/2018
Tom Baker Cancer Centre - Calgary
mi
from
Calgary,
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Timing of Rectal Cancer Response to Chemoradiation
Status: Enrolling
Updated: 4/5/2018
Tom Baker Cancer Centre - Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial
Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  4/5/2018
University of California at San Francisco
mi
from
San Francisco, CA
Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial
Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 4/5/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/6/2018
START Midwest
mi
from
Grand Rapids, MI
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/6/2018
START Midwest
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/6/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/6/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/6/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/6/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/6/2018
Massachusetts General Hospital
mi
from
Boston, MA
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/6/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/6/2018
Moffitt Cancer Center
mi
from
Tampa, FL
Study of ASN003 in Subjects With Advanced Solid Tumors
A Phase 1, Open-label, Dose-finding and Cohort Expansion Study of ASN003 in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/6/2018
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Phase II, Randomized, Placebo-Controlled Study of Minocycline for Reducing Symptom Burden in Patients With Colorectal Cancer
Status: Enrolling
Updated:  4/11/2018
LBJ Hospital
mi
from
Houston, TX
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Phase II, Randomized, Placebo-Controlled Study of Minocycline for Reducing Symptom Burden in Patients With Colorectal Cancer
Status: Enrolling
Updated: 4/11/2018
LBJ Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Phase II, Randomized, Placebo-Controlled Study of Minocycline for Reducing Symptom Burden in Patients With Colorectal Cancer
Status: Enrolling
Updated:  4/11/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Phase II, Randomized, Placebo-Controlled Study of Minocycline for Reducing Symptom Burden in Patients With Colorectal Cancer
Status: Enrolling
Updated: 4/11/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors (COACH)
Status: Enrolling
Updated:  4/24/2018
Johns Hopkins Center to Reduce Cancer Disparities
mi
from
Baltimore, MD
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors (COACH)
Status: Enrolling
Updated: 4/24/2018
Johns Hopkins Center to Reduce Cancer Disparities
mi
from
Baltimore, MD
Click here to add this to my saved trials
Partnership for Healthy Seniors
Cancer Prevention and Treatment Among African American Older Adults: Screening Trial
Status: Enrolling
Updated:  4/24/2018
Bloomberg School of Public Health
mi
from
Baltimore, MD
Partnership for Healthy Seniors
Cancer Prevention and Treatment Among African American Older Adults: Screening Trial
Status: Enrolling
Updated: 4/24/2018
Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Parkland-UT Southwestern PROSPR Center: Colon Cancer Screening in a Safety Net: Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Status: Enrolling
Updated:  4/25/2018
Parkland Health and Hospital System
mi
from
Dallas, TX
Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Parkland-UT Southwestern PROSPR Center: Colon Cancer Screening in a Safety Net: Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Status: Enrolling
Updated: 4/25/2018
Parkland Health and Hospital System
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
The Mayo Clinic
mi
from
Rochester, MN
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
Tennessee Oncology / Sarah Cannon Research Institute
mi
from
Nashville, TN
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
Tennessee Oncology / Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
Status: Enrolling
Updated:  4/27/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
Status: Enrolling
Updated: 4/27/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
Status: Enrolling
Updated:  4/27/2018
University of Illinois College of Medicine - Chicago
mi
from
Chicago, IL
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
Status: Enrolling
Updated: 4/27/2018
University of Illinois College of Medicine - Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
Status: Enrolling
Updated:  4/27/2018
The Mayo Clinic
mi
from
Rochester, MN
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
Status: Enrolling
Updated: 4/27/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated:  4/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated: 4/30/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated:  4/30/2018
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated: 4/30/2018
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated:  4/30/2018
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated: 4/30/2018
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
Click here to add this to my saved trials
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated:  4/30/2018
Univ of Minnesota
mi
from
Minneapolis, MN
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated: 4/30/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated:  4/30/2018
University Hospital of Cleveland, Case Medical Center, Seidman Cancer Center
mi
from
Cleveland, OH
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated: 4/30/2018
University Hospital of Cleveland, Case Medical Center, Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated:  4/30/2018
Institut Jules Bordet
mi
from
Bruxelles,
An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Status: Enrolling
Updated: 4/30/2018
Institut Jules Bordet
mi
from
Bruxelles,
Click here to add this to my saved trials
Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
Navigated Early Survivorship Transition in Improving Survivorship Care Planning in Patients With Newly Diagnosed Cancer and Their Caregivers (NEST)
Status: Enrolling
Updated:  5/1/2018
Meharry Medical College
mi
from
Nashville, TN
Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
Navigated Early Survivorship Transition in Improving Survivorship Care Planning in Patients With Newly Diagnosed Cancer and Their Caregivers (NEST)
Status: Enrolling
Updated: 5/1/2018
Meharry Medical College
mi
from
Nashville, TN
Click here to add this to my saved trials
Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
Navigated Early Survivorship Transition in Improving Survivorship Care Planning in Patients With Newly Diagnosed Cancer and Their Caregivers (NEST)
Status: Enrolling
Updated:  5/1/2018
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
Navigated Early Survivorship Transition in Improving Survivorship Care Planning in Patients With Newly Diagnosed Cancer and Their Caregivers (NEST)
Status: Enrolling
Updated: 5/1/2018
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated:  5/2/2018
Lincoln Hospital and Mental Health Center
mi
from
Bronx, NY
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated: 5/2/2018
Lincoln Hospital and Mental Health Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated:  5/2/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated: 5/2/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated:  5/2/2018
Ralph Lauren Center for Cancer Care and Prevention
mi
from
New York, NY
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated: 5/2/2018
Ralph Lauren Center for Cancer Care and Prevention
mi
from
New York, NY
Click here to add this to my saved trials
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated:  5/2/2018
Lutheran Medical Center
mi
from
Brooklyn, NY
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Status: Enrolling
Updated: 5/2/2018
Lutheran Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials